This site is intended for healthcare professionals only
LoginRegister
Exemed Pharmaceutical gets CDSCO panel nod to Manufacture, market FDC Bempedoic Acid plus Atorvastatin CalciumExemed Pharmaceutical gets CDSCO panel nod to Manufacture, market FDC Bempedoic Acid plus...
Novartis intrathecal onasemnogene abeparvovec Phase III studyNovartis to prioritise US market, unfazed by drug pricing pushback
CDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of AZD9977,Dapagliflozin FDCCDSCO panel opines Paraxel to study either CKD or heart failure in phase IIb trial of...
GSK Nucala application for COPD accepted for review in ChinaGSK, Spero Therapeutics ink pact for complicated urinary tract infections antibiotic Tebipenem...
AstraZeneca discontinues Phase 3 trial of prostate cancer drug TruqapAstraZeneca Ultomiris approved in Europe for treatment of adults with generalised myasthenia gravis
Moderna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, childrenModerna seeks USFDA nod for Omicron-targeted COVID vaccine for adolescents, children
CDSCO panel rejects Sanofi clinical study report on Hexavalent vaccineCDSCO panel rejects Sanofi clinical study report on Hexavalent vaccine
GSK Nucala application for COPD accepted for review in ChinaGSK announces USFDA committee to review Zejula overall survival data from NOVA phase III trial in...
PCI to amend Diploma in Pharmacy Exit Examination Regulation 2022PCI to amend Diploma in Pharmacy Exit Examination Regulation 2022
AstraZeneca, Merck get Chinese nod for Lynparza to treat ovarian cancerAstraZeneca, Merck get Chinese nod for Lynparza to treat ovarian cancer
Need to fast-track regulatory processes for biotech sector: CII ReportNeed to fast-track regulatory processes for biotech sector: CII Report
Cipla gets USFDA EIR for Indore facilityCipla gets USFDA EIR for Indore facility
X